What Артрум Treats: Main Uses and Benefits

The medication is commonly used in settings where symptoms create noticeable functional strain, primarily addressing discomfort associated with musculoskeletal conditions and inflammation. This class of medication is considered relevant for managing symptoms of pain and inflammation.

Артрум is applied across therapeutic domains involving heightened symptoms, helping to manage aches, soreness, localized pain, physical swelling, and stiffness. It is relevant in conditions characterized by periods of heightened symptoms, such as those involving sudden episodes or temporary flare-ups.

This supportive relief helps the patient cope more steadily with difficult episodes.

“Applied in scenarios where additional management of discomfort is required, this medicine provides symptomatic relief that assists with maintaining functional stability.”

Quick Fact: Relief for Pain and Inflammation

---

Relief for Pain and Aches

This medication is used in situations involving symptoms related to physical discomfort, providing relief from aches, soreness, and localized pain. It helps address symptom clusters that may become intense or disruptive, contributing to improved comfort during periods of heightened symptoms.

Management of Inflammation and Swelling

Артрум is applied in contexts where additional symptomatic support is needed, specifically targeting symptoms related to inflammatory or irritative states, such as physical swelling and tenderness. It assists with managing symptoms that create noticeable functional strain.

Support for Physical Functioning

The medication is relevant in conditions characterized by restricted movement or stiffness caused by discomfort. It offers symptomatic relief that helps patients cope more steadily with difficult episodes, supporting the patient during difficult episodes by easing distress and assisting with maintaining functional stability.

Regulatory References

1. NIH MedlinePlus overview of NSAIDs

The official regulatory profile for Артрум (Artrom) establishes clear criteria for who is eligible to use the medicine and who is strictly prohibited.

Eligibility Scope

Scope Item	Regulatory Status
Populations for whom use is allowed	Generally, adults (ge 18 years of age) without listed contraindications.
Populations for whom use is contraindicated	Individuals with known hypersensitivity to the drug or any component. Patients with an officially designated active, life-threatening clinical condition (e.g., active bleeding or severe, decompensated organ failure) must not use the medicine.

Age- and Condition-Based Restrictions

Restriction Type	Official Regulatory Status
Age-related rules	Safety and efficacy have not been established for the paediatric population (under 18 years).
Organ Function	Severe hepatic or renal impairment is often an absolute prohibition due to compromised drug metabolism or elimination. Moderate impairment requires special caution or dosage modification.
Pregnancy and Lactation	Use during pregnancy is often prohibited or not recommended, and breastfeeding is generally not recommended to avoid potential exposure.

These official statements structure the eligibility profile, classifying use as contraindicated (absolutely prohibited), not established (lacking regulatory data for use), or requiring special caution.

The topical nature of Артрум (Ketoprofen gel) results in very low systemic absorption, meaning that most systemic drug-drug interactions documented for oral NSAIDs are considered unlikely by regulatory authorities.

Pharmacodynamic and Local Interactions

The official interaction profile is characterized by restrictions related to local skin application and class-based hypersensitivity, often classified as contraindications in official documents.

Classification	Interacting Substance/Condition	Restriction
Contraindicated Combination	Octocrylene-containing products (e.g., sunscreens, cosmetics)	Co-application on treated skin is strictly prohibited due to severe photosensitivity risk.
Timing-Based Restriction	UV Light Exposure (Sunlight, Solariums)	The treated skin must not be exposed to UV light during treatment and for a mandatory period of two weeks after discontinuing the medicine.
Cross-Hypersensitivity	Other NSAIDs, Aspirin, Tiaprofenic acid, Fenofibrate	Contraindicated in patients with a history of allergic reactions (e.g., asthma, allergic rhinitis) to these chemically related substances.

The regulatory basis for these rules emphasizes the need to avoid the compounding risk of local phototoxicity and to prevent cross-allergic responses known to occur within the Non-Steroidal Anti-Inflammatory Drug class. There are no documented metabolic, transporter-mediated, food, or alcohol interactions for this topical formulation.

How Артрум Works — Mechanism of Action

Enzyme Target and Pathway Modulation

Артрум, functioning as a nonsteroidal anti-inflammatory drug, operates through the non-selective inhibition of the Cyclooxygenase ( COX-1 and COX-2) enzymes. The active substance competitively and reversibly binds to the enzyme active sites, thereby blocking the initial conversion of arachidonic acid into prostaglandins, thromboxanes, and prostacyclins.

---

Systemic Physiological Consequences

The resulting suppression of prostaglandin synthesis affects multiple physiological systems. Peripherally, the reduction in prostaglandin concentration lowers the sensitization threshold of nociceptors and limits inflammatory vascular permeability, resulting in decreased pain signal transduction and reduced tissue edema. Centrally, the inhibition of prostaglandin synthesis in the hypothalamus prevents the abnormal elevation of the thermoregulatory set-point during febrile states, which initiates heat dissipation mechanisms to change core temperature. Non-selective inhibition also includes COX-1, which modulates homeostatic functions, including the aggregation of platelets and gastric mucosal processes.

Official Administration Guidelines

Артрум is an official topical dosage form (gel or solution) intended for direct cutaneous application to the skin. The official instructions for use dictate the specific method, frequency, and duration of application, as outlined in official documentation.

---

Usage Parameter	Instruction
Route of Administration	Topical; For external use only and applied directly to the skin surface.
Standard Adult Dose	Apply a length of gel, typically 5 to 10 cm (corresponding to approximately 100 to 200 mg of Ketoprofen), to the localized affected area.
Dosing Frequency	Applied two to three times daily (BID or TID).
Course Duration	Treatment should be for the shortest duration necessary and generally should not exceed 7 to 10 days.
Pediatric Use	Not recommended for use in children under 12 or 15 years of age due to lack of established safety and efficacy data.

---

Procedural Instructions for Application

The product must be used strictly in accordance with the following procedural steps documented in the official labeling:

• Method: Apply the measured dose of gel and rub gently into the skin with a prolonged massage to ensure local absorption.
• Restrictions: The gel must not be used with occlusive or air-tight dressings. It must not be applied to mucous membranes, open wounds, or damaged skin.
• Post-Application: Hands should be washed thoroughly immediately after each application unless the treated area is the hands themselves.

These instructions define a precise, standardized protocol for the external delivery of the medicine, ensuring that the dosage and duration limits established for the product are followed.

Research Evidence Summary for Topical Ketoprofen

This overview describes the official research available for topical ketoprofen, the active ingredient in Артрум, focusing on what has been studied in clinical trials and meta-analyses. This information is intended only to provide context on the evidence base, not to offer any clinical guidance.

---

Evidence for Acute Localized Musculoskeletal Conditions

The primary evidence consists of short-term Randomized Controlled Trials (RCTs) examining adults with sudden soft tissue injuries like sprains, strains, and contusions. These RCTs examined outcomes related to spontaneous pain intensity and pain during daily functioning over short intervals, typically less than two weeks. Findings describe patterns observed in these studies compared to a placebo vehicle, but results apply only to the studied adult cohorts and acute timeframe.

---

Evidence for Chronic Localized Conditions (Osteoarthritis)

Research for chronic conditions, such as Osteoarthritis of the knee and hand, used intermediate-term RCTs lasting six to twelve weeks. Studies explored patient-reported outcomes describing changes in pain subscale scores and physical function. In these trials, data show patterns related to measured changes in participant scores when compared to a placebo vehicle, though the distinction between findings for the active medicine and the vehicle alone is a known consideration in the research landscape.

---

Key Areas of Research Uncertainty and Study Gaps

The research structure consistently highlights limited follow-up durations, meaning long-term effects are not fully established beyond the trial periods. Evidence for certain populations, such as children, adolescents, or patients with complex co-existing conditions, remains insufficient. Similarly, high-quality data are limited for conditions like hip or spinal osteoarthritis, where most evidence applies specifically to the knee.

Common questions about Артрум (FAQ)

---

Q: What should I do if I miss a dose of the medicine?

The official product information states that if a dose is missed, it can be applied when it is remembered. However, it is essential not to exceed the maximum daily dose that has been authorized. The label cautions against applying a double dose to make up for a missed application.

---

Q: Can children use the Артрум gel?

Official regulatory documents indicate that the use of this medicine is not recommended for children and adolescents under 15 years of age. This restriction is in place because the safety and effectiveness of the gel have not been fully established in official studies for this younger age group.

---

Q: What should I do if the gel is expired?

Expired or unused medicine must not be disposed of in general household waste or flushed down the sink. Regulatory guidelines advise returning these products to a community pharmacy. Pharmacists can advise on disposal through official pharmaceutical waste programs to meet local environmental requirements.

---

Q: Is it okay to use my regular sunscreen on the area I’m treating?

Official product information specifically contraindicates the use of any product containing the ingredient Octocrylene on the treated skin, as this can severely increase the risk of a photosensitivity (reaction to light). Furthermore, regulatory constraints state that the treated area must be protected from all sunlight and UV light, typically by wearing clothing, during treatment and for a period of two weeks after stopping the gel.

---

Q: What should I do if I use too much gel at once?

Due to its topical (on the skin) route of administration, an overdose of this gel is generally considered unlikely with intended use. However, applying excessive amounts or accidental ingestion may potentially lead to systemic effects. For any concerns about accidental overdose or ingestion, regulatory labels suggest seeking supportive and symptomatic care.

How to Store and Dispose of Артрум?

Артрум (Ketoprofen topical gel) must be stored strictly according to official regulatory specifications to maintain its stability.

Storage Requirements

The gel must be stored within a temperature range that generally does not exceed 25 C or 30 C and must be kept from freezing. The medication should be kept in its original container and must remain tightly closed to prevent evaporation and contamination. It is required to store the gel away from naked flames and excess heat or moisture. For safety, this medicine must always be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Артрум should not be thrown away via wastewater or general household waste. Disposal must follow the instructions of a pharmacist or adhere to local environmental requirements for pharmaceutical waste.